Molecular Characterization of the 229E Strain of Human Coronavirus

  • Nathalie Arpin
  • Pierre J. Talbot
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 276)


Human coronaviruses (HCV) cause various respiratory, gastrointestinal and possibly neurological disorders. Very little is known of the molecular biology of these ubiquitous pathogens. We have undertaken the molecular characterization of the prototype 229E strain of HCV. The virus grew to the highest titers on a human embryonic lung cell line (L132) at 33°C and purification was optimal on Renografin-60® gradients. Metabolic labeling with [35S]methionine or [3H] glucosamine or galactose and analysis by SDS-PAGE revealed at least five structural proteins, which could be identified by analogy with murine coronaviruses as follows: the spike glycoprotein (E2/S), in both monomelic (88–97 kDa) and dimeric (190–200) forms, the nucleoprotein (N) at 52–53 kDa and the matrix protein (El/M), in both glycosylated (25–26 kDa) and non-glycosylated (20–22 kDa) forms. Monomeric, dimeric and multimeric (>200 kDa) forms of E2/S incorporated glucosamine and galactose, whereas only galactose was incorporated into El/M. Mult mers of El/M, with apparent molecular masses of 44, 74 and 140 kDa, were formed in the absence of a reducing agent.


Multiple Sclerosis Patient L132 Cell Apparent Molecular Mass Infectious Titer Human Coronavirus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    M.R. Macnaughton, M.H. Madge, and S.E. Reed, Two antigenic groups of human coronaviruses detected by using enzyme-linked immunosorbent assay, Infect. Immun.33:734(1981).PubMedGoogle Scholar
  2. 2.
    K. Mcintosh. Coronaviruses. A comparative review, Curr. Top. Microbiol. Immu nol. 63: 85 (1974).Google Scholar
  3. 3.
    R. Tanaka, Y. Iwasaki, and H. Koprowski, Intracisternal virus-like particles in brain of a multiple sclerosis patient, J. Neurol. Sci. 28: 121 (1976).PubMedCrossRefGoogle Scholar
  4. 4.
    J.S. Burks, B.L. DeVals, L.D. Jankovsky, and J.C. Gerdes, Two coronaviruses isolated from central nervous system of two multiple sclerosis patients, Science209: 933 (1980).PubMedCrossRefGoogle Scholar
  5. 5.
    A. Salmi, B. Ziola, T. Hovi, and M. Reunanen, Antibodies to coronaviruses OC43 and 229E in multiple sclerosis patients, Neurology 32: 292 (1982).PubMedGoogle Scholar
  6. 6.
    E.V. Davis, and V.S. Bolin, Continuous cultivation of isogenous cell lines from the human embryo, Fed. Proc. 19: 386 (1960).Google Scholar
  7. 7.
    G. Chaloner-Larsson, and M. Johnson-Lussenburg, Establishment and maintenance of a persistent infection of LI32 cells by human Coronavirus strain 229E, Arch. Virol. 69: 117 (1981).PubMedCrossRefGoogle Scholar
  8. 8.
    R.M. MacAllister, J. Melnyk, J.Z. Finklestein, E.C. Adams, and M.B. Gardner, Cultivation in vitro of cells derived from a human rhabdomyosarcoma, Cancer 24: 520 (1969).CrossRefGoogle Scholar
  9. 9.
    O.W. Schmidt, M.K. Cooney, and G.E. Kenny, Plaque assay and improved yield of human coronaviruses in a human rhabdomyosarcoma cell line, J. Clin. Micro-bioL9:722(1979).Google Scholar
  10. 10.
    W.A.F. Tompkins, A.M. Watrach, J.D. Schmale, R.M. Schulze, and J.A. Harris, Culture and antigenic properties of newly established cell strains derived from adenocarcinomas of the human colon and rectum, J. Natl. Cancer Inst. 52: 101 (1974).Google Scholar
  11. 11.
    C. Daniel, and P.J. Talbot, Physico-chemical properties of murine hepatitis virus, strain A59, Arch. Virol. 96: 241 (1987).CrossRefGoogle Scholar
  12. 12.
    U.K. Laemmli, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature (Lond.) 227: 680 (1970).CrossRefGoogle Scholar
  13. 13.
    J.C. Hierholzer, Purification and biophysical properties of human Coronavirus 229E, Virology 75: 155 (1976).PubMedCrossRefGoogle Scholar
  14. 14.
    M.R. Macnaughton, The polypeptides of human and mouse coronaviruses, Arch. Virol. 63: 75 (1980).PubMedCrossRefGoogle Scholar
  15. 15.
    O.W. Schmidt, and G.E. Kenny, Polypeptides and functions of antigens from human coronaviruses 229E and OC43, Infect. Immun. 35: 515 (1982).PubMedGoogle Scholar
  16. 16.
    L.S. Sturman, Characterization of a Coronavirus. I. Structural proteins: Effects of preparative conditions on the migration of protein in Polyacrylamide gels, Virology77: 637 (1977).PubMedCrossRefGoogle Scholar
  17. 17.
    L.S. Sturman, K.V. Holmes, and J. Behnke, Isolation of Coronavirus envelope glycoproteins and interaction with the viral nucleocapsid, J. Virol. 33: 449 (1980).PubMedGoogle Scholar
  18. 18.
    B.G. Hogue, and D.A. Brian, Structural proteins of human respiratory Coronavirus OC43. Virus Res. 5: 131 (1986).PubMedCrossRefGoogle Scholar
  19. 19.
    J.O. Fleming, R.A. Shubin, M.A. Sussman, N. Casteel, and S.A. Stohlman, Monoclonal antibodies to the matrix (El) glycoprotein of mouse hepatitis virus protect mice from encephalitis, Virology 168: 162 (1989).PubMedCrossRefGoogle Scholar
  20. 20.
    P.J. Talbot, and M.J. Buchmeier. Antigenic variation among murine coronaviruses: Evidence for polymorphism on the peplomer glycoprotein, E2, Virus Res. 2: 317 (1985).CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • Nathalie Arpin
    • 1
  • Pierre J. Talbot
    • 1
  1. 1.Virology Research Center Institut Armand-FrappierUniversité du QuébecLavalCanada

Personalised recommendations